Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645
This examiner grants 69% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18029857 | METHODS AND MATERIALS FOR TREATING GASTROINTESTINAL DISORDERS | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18564939 | FERMENTATION METHOD FOR PRODUCING MALONIC ACID | Non-Final OA | CARGILL, INCORPORATED |
| 18314024 | NANOEMULSION AND METHODS OF USE THEREOF | Non-Final OA | Washington University |
| 18470948 | COMPOSITIONS, SYSTEMS, AND METHODS FOR REDUCING ELECTROSENSATION AND/OR SKIN IRRITATION | Non-Final OA | Novocure GmbH |
| 18060048 | IN VIVO USE OF CHONDROITINASE AND/OR HYALURONIDASE TO ENHANCE DELIVERY OF AN AGENT | Final Rejection | Inovio Pharmaceuticals, Inc. |
| 18293539 | CLOSTRIDIUM CHAUVOEI VACCINE AND METHOD OF MAKING | Non-Final OA | Zoetis Services LLC |
| 18402174 | BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18441311 | Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition | Non-Final OA | Wyeth LLC |
| 18425385 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY AND RELATED DISORDERS | Non-Final OA | Finch Therapeutics Holdings LLC |
| 18285890 | PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA | Non-Final OA | Evelo Biosciences, Inc. |
| 18027003 | SOLID DOSAGE FORMS OF BACTERIA | Non-Final OA | Evelo Biosciences, Inc |
| 18259124 | METHOD FOR IMPROVING PRODUCTIVITY IN LIVESTOCK AND/OR POULTRY AND METHOD FOR IMPROVING INTESTINAL FLORA IN LIVESTOCK AND/OR POULTRY | Non-Final OA | Hayashibara Co., Ltd. |
| 17911089 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING CARDIOVASCULAR DISORDERS | Non-Final OA | AEON Biopharma Sub, Inc. |
| 18122527 | METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES | Non-Final OA | Serimmune Inc. |
| 18022895 | PLASMID ADDICTION SYSTEMS | Non-Final OA | GreenLight Biosciences, Inc. |
| 17999516 | HIGH-COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES | Non-Final OA | Federation Bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy